spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cesium 

 HSMN NewsFeed - 26 Apr 2018
Agfa Receives FDA 510(k) Clearance for DR 800 Multi-purpose Digital Imaging System
Devices Radiology FDA
 HSMN NewsFeed - 25 Sep 2017
IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology (ASTRO) Conference
Devices Oncology
 HSMN NewsFeed - 7 Jul 2017
IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer
Devices Oncology Personnel
 HSMN NewsFeed - 6 Jul 2017
IsoRay Receives FDA Response to 510(k) Application for GammaTile(TM)
Devices Oncology FDA
 HSMN NewsFeed - 10 Mar 2017
IsoRay Announces Final Court Approval of Class Action Settlement
Devices Oncology Litigation
 HSMN NewsFeed - 27 Sep 2016
IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation
Devices Oncology Litigation
 HSMN NewsFeed - 14 Jan 2016
IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15
Devices Oncology Personnel
 HSMN NewsFeed - 5 Aug 2014
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Devices Neurosurgery Oncology
 HSMN NewsFeed - 20 Jun 2014
IsoRay Announces New Russian and Peruvian International Distributor Agreements for the Sale of IsoRay's Full Line of Products
Devices Oncology Distribution
 HSMN NewsFeed - 21 May 2014
El Camino Hospital Installs Five Carestream DRX Imaging Systems to Perform Portable X-ray Exams at Two Campuses
Devices Radiology
 HSMN NewsFeed - 12 May 2014
IsoRay's Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System
Devices Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
Devices Oncology
 HSMN NewsFeed - 29 Jan 2014
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
Devices Oncology Regulatory
 HSMN NewsFeed - 7 Jan 2014
FDA Clears IsoRay's Liquid Cesium (Cesitrex)(TM) for Use With GliaSite(R) in Treating Glioblastomas and Metastatic Brain Cancers
Devices Oncology FDA
 HSMN NewsFeed - 19 Dec 2013
University of California San Diego and John Muir Medical Center Initiate Treating Patients for Colon and Lung Cancer Utilizing IsoRay's Cesium-131 Seeded Mesh
Devices Oncology
 HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 11 Dec 2012
IsoRay's Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell and Barrow Neurological to The Society Of Neuro-Oncology
Devices Oncology
 HSMN NewsFeed - 29 Oct 2012
IsoRay's Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
Devices Oncology
 HSMN NewsFeed - 5 Jun 2012
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 22 May 2012
IsoRay’s GliaSite Approved for Sale in 31 European Countries
Devices Oncology Regulatory
 HSMN NewsFeed - 7 May 2012
IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy
Devices Oncology
 HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
Devices Oncology Distribution
 HSMN NewsFeed - 12 Sep 2011
FDA Clears IsoRay's GliaSite(R) Treatment for Brain Cancer
Devices Oncology FDA
 HSMN NewsFeed - 12 Jul 2011
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
Devices Oncology
 HSMN NewsFeed - 7 Jun 2011
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex(R) for GliaSite(R) Brain Cancer Treatment
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 27 Oct 2010
Successful IsoRay Study of Cesium-131 Internal Radiation Therapy for Breast Cancer Paves the Way for Advanced Treatment
Devices Oncology
 HSMN NewsFeed - 13 Oct 2010
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
Devices Oncology
 HSMN NewsFeed - 7 Oct 2010
IsoRay Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer
Devices Oncology
 HSMN NewsFeed - 23 Jun 2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
Devices Oncology Licensing
 HSMN NewsFeed - 27 Jan 2010
IsoRay Hires Vice President of Research and Development
Devices Oncology Personnel
 HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
Devices Oncology
 HSMN NewsFeed - 3 Dec 2009
IsoRay Announces Iodine Distribution Agreement with GE Subsidiary, Oncura
Devices Oncology Distribution
 HSMN NewsFeed - 18 Nov 2009
IsoRay Announces Distribution Agreement in Canada
Devices Oncology Distribution
 HSMN NewsFeed - 18 Aug 2009
IsoRay Announces FDA Clearance Supporting Enhanced Loading and Delivery Methods for the Treatment of Lung, Head and Neck, and Other Tumors
Devices Oncology FDA
 HSMN NewsFeed - 27 Feb 2008
IsoRay Appoints New Chairman and Interim CEO and Announces Management Changes upon Incumbent Resignation
Devices Personnel
 HSMN NewsFeed - 4 Jan 2008
New Chairman for Oncologix Tech, Inc. Issues Statement
Devices Oncology Personnel
 HSMN NewsFeed - 1 Nov 2007
New Studies Unveiled at ASTRO's 49th Annual Meeting of Radiation Oncology Specialists Support the Effectiveness of IsoRay Medical's Proxcelan(TM) for the Treatment of Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 1 Oct 2007
IsoRay Announces Global Strategic Alliance with IBt s.a.
Devices Oncology
 HSMN NewsFeed - 30 Aug 2007
IsoRay Medical, Inc., Set to Transfer Production of Proxcelan(TM) (Cesium-131) Brachytherapy Seeds to New Expanded Facilities in Richland
Devices Oncology
 HSMN NewsFeed - 9 Aug 2007
Leading Medical Centers Join Growing Number of Locations Offering IsoRay's Prostate Cancer Treatment Proxcelan(TM) Brachytherapy Seeds (Cesium-131)
Devices Oncology
 HSMN NewsFeed - 20 Jul 2007
IsoRay Medical, Inc. Introduces Branding of Cesium-131 as Proxcelan(TM) for Use in Prostate Cancer Brachytherapy
Devices Oncology
 HSMN NewsFeed - 20 Jul 2007
Scientific Abstracts on Newest Isotope Used in Brachytherapy for Prostate Cancer -- IsoRay's Proxcelan(TM) with Cesium-131
Devices Oncology
 HSMN NewsFeed - 30 Apr 2007
New Study Shows That Cesium-131 From IsoRay Medical(TM) Is an Effective, Well-Tolerated Brachytherapy Treatment for Prostate Cancer with Fewer Side Effects Than Other Medical Isotopes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Apr 2007
Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer Treatment in a Recent Clinical Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2006
Canon Expands Its Line of Digital Radiography Offerings with the Introduction of the Canon CXDI-40EC System
Devices Radiology
 HSMN NewsFeed - 7 Jul 2006
Varian Medical Systems Introduces PaxScan(R) Digital X-ray Image Detector for Dental, Medical, and High-Volume Semiconductor Inspection Markets
Devices Radiology
 HSMN NewsFeed - 28 Jun 2006
IsoRay Medical Names Eric Knipfer Southeast Area Director as Company Expands Business Development Initiatives
Devices Oncology Personnel
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
cesium
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.